These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6089553)

  • 21. [How to prescribe converting enzyme inhibitors].
    Castaigne A; Duval-Moulin AM; Dubois-Rande JL
    Rev Prat; 1988 Mar; 38(10):626-30. PubMed ID: 3375764
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of captopril in therapeutic combinations].
    Alföldi S
    Acta Pharm Hung; 1997 Jul; 67(4):149-53. PubMed ID: 9289943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of angiotensin-converting enzyme: therapeutic implications.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
    [No Abstract]   [Full Text] [Related]  

  • 24. [Administration of captopril (aceten++, ++"Vokhardt"++) in hypertension and congestive heart failure].
    Balakhonova NP; Avdeev VG; Kuznetsov NE; Liapon DO; Senchikhin PV
    Klin Med (Mosk); 1997; 75(1):42-3. PubMed ID: 9082059
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antihypertensive therapy using a combination of angiotensin-1 receptor inhibitors and angiotensin-converting enzyme inhibitors].
    Schute L
    Dtsch Med Wochenschr; 1998 Oct; 123(43):1295. PubMed ID: 9818002
    [No Abstract]   [Full Text] [Related]  

  • 26. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Angiotensin converting enzyme inhibitors in arterial hypertension and cardiac failure. The question of the dose].
    González-Juanatey JR
    Med Clin (Barc); 2000; 114 Suppl 2():24-7. PubMed ID: 10916802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
    Ferguson RK; Vlasses PH; Riley LJ
    Ration Drug Ther; 1984 Mar; 18(3):1-5. PubMed ID: 6093192
    [No Abstract]   [Full Text] [Related]  

  • 29. Class effects of angiotensin-converting enzyme inhibitors.
    Sica DA
    Am J Manag Care; 2000 Feb; 6(3 Suppl):S85-108; quiz S109-11. PubMed ID: 10977451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term use of angiotensin-converting enzyme inhibitors to modify endothelial dysfunction: a review of clinical investigations.
    Mancini GB
    Clin Invest Med; 2000 Apr; 23(2):144-61. PubMed ID: 10852664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Angiotensin converting enzyme inhibitors in arterial hypertension].
    Ramón González-Juanatey J
    Rev Esp Cardiol; 1999; 52 Suppl 3():73-8. PubMed ID: 10614152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of angiotensin-converting enzyme inhibitors on managed care: economic, clinical, and humanistic outcomes.
    Reeder CE; Gourley GA; Wurtzbacher JD; Reed P
    Am J Manag Care; 2000 Feb; 6(3 Suppl):S112-28, quiz S129-31. PubMed ID: 10977441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Various ACE inhibitors are available for treatment of arterial hypertension and heart failure].
    Schwartzkopff B
    Internist (Berl); 1993 Aug; 34(8):796. PubMed ID: 8375995
    [No Abstract]   [Full Text] [Related]  

  • 35. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
    Leary AC; MacDonald TM
    Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific properties and effect of perindopril in controlling the renin-angiotensin system.
    Ferrari R; Pasanisi G; Notarstefano P; Campo G; Gardini E; Ceconi C
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):142S-154S. PubMed ID: 16125051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors.
    Juggi JS; Koenig-Berard E; Van Gilst WH
    Can J Cardiol; 1993 May; 9(4):336-52. PubMed ID: 8513428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension.
    Schellenbaum GD; Smith NL; Heckbert SR; Lumley T; Rea TD; Furberg CD; Lyles MF; Psaty BM
    J Am Geriatr Soc; 2005 Nov; 53(11):1996-2000. PubMed ID: 16274385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C; Cosentino E; De Sanctis D
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of congestive heart failure. II. Vasodilators and angiotensin-converting enzyme inhibitors.
    Aronow WS
    Ration Drug Ther; 1982 Oct; 16(10):1-5. PubMed ID: 6294740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.